Thrivent Financial for Lutherans Acquires 8,323 Shares of Masimo Corporation $MASI

Thrivent Financial for Lutherans boosted its holdings in Masimo Corporation (NASDAQ:MASI) by 56.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 23,174 shares of the medical equipment provider’s stock after acquiring an additional 8,323 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Masimo were worth $3,014,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Pinnacle Associates Ltd. bought a new position in Masimo in the 4th quarter worth about $217,000. Allworth Financial LP increased its stake in Masimo by 87.3% in the 4th quarter. Allworth Financial LP now owns 1,695 shares of the medical equipment provider’s stock worth $220,000 after acquiring an additional 790 shares during the last quarter. Versor Investments LP increased its stake in Masimo by 58.3% in the 4th quarter. Versor Investments LP now owns 3,564 shares of the medical equipment provider’s stock worth $464,000 after acquiring an additional 1,312 shares during the last quarter. Wilson Asset Management International PTY Ltd. increased its stake in Masimo by 44.8% in the 4th quarter. Wilson Asset Management International PTY Ltd. now owns 39,437 shares of the medical equipment provider’s stock worth $5,129,000 after acquiring an additional 12,203 shares during the last quarter. Finally, Cardinal Capital Management increased its stake in Masimo by 1.3% in the 4th quarter. Cardinal Capital Management now owns 21,462 shares of the medical equipment provider’s stock worth $2,791,000 after acquiring an additional 282 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

Masimo Price Performance

Shares of Masimo stock opened at $178.81 on Friday. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $9.36 billion, a PE ratio of -16.96, a price-to-earnings-growth ratio of 1.81 and a beta of 1.13. The business’s 50-day moving average price is $178.12 and its 200-day moving average price is $157.09. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.00.

Analyst Ratings Changes

A number of brokerages have weighed in on MASI. Wolfe Research lowered Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a research report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 price objective on Masimo in a research report on Tuesday, February 17th. Piper Sandler lowered Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective on the stock. in a research report on Tuesday, February 17th. Finally, Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Nine analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Masimo has an average rating of “Hold” and an average price target of $180.40.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.